Ghana pharma ramps up with generics facility investor

Investment concern Emerging World Pharma reports progress in the development of a drug manufacturing facility in Ghana. The plant will be used by African Global Pharma to produce generic drugs.

Three shipping containers of production equipment and supplies are en route to port in Ghana, Emerging World Pharma President Brandon Keks says in an announcement. Raw materials are being shipped by air. "We are on schedule to begin test runs for the production of several generic pharmaceuticals by the end of May," Keks adds.

Plans call for production of 13 generics initially, to be followed by 18 more as capacity expands. Employment agreements for production and administrative staff are in process, says Keks. "We have an experienced and excited team ready to go to work."

Emerging World Pharma invests in generic drugmakers that have contracts with three buyer groups: Church, government and wholesalers.

- here's the release

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.